日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Alkylation of Aromatic Compounds with Pentabromobenzyl Bromide and Tetrabromoxylene Dibromide as a New Route to High Molecular Weight Brominated Flame Retardants

五溴苄基溴和四溴二甲苯二溴化物对芳香族化合物进行烷基化反应，合成高分子量溴代阻燃剂的新方法

期刊:Polymers
影响因子:
doi:10.3390/polym12020352
Mark Gelmont, Michael Yuzefovitch, David Yoffe, Eyal Eden, Sergei Levchik
信号转导
发表日期：2020
文献求助 收藏

Sub-terahertz vibrational spectroscopy of ovarian cancer and normal control tissue for molecular diagnostic technology

利用亚太赫兹振动光谱技术对卵巢癌和正常对照组织进行分子诊断

期刊:Cancer Biomarkers
影响因子:1.9
doi:10.3233/CBM-182120
Globus, Tatiana; Moskaluk, Christopher; Pramoonjago, Patcharin; Gelmont, Boris; Moyer, Aaron; Bykhovski, Alexei; Ferrance, Jerome
肿瘤
肿瘤免疫
卵巢癌
发表日期：2019
文献求助 收藏

A phase 3 trial of IV immunoglobulin for Alzheimer disease

一项针对阿尔茨海默病的静脉注射免疫球蛋白的3期临床试验

期刊:Neurology
影响因子:8.5
doi:10.1212/WNL.0000000000003904
Relkin, Norman R; Thomas, Ronald G; Rissman, Robert A; Brewer, James B; Rafii, Michael S; van Dyck, Christopher H; Jack, Clifford R; Sano, Mary; Knopman, David S; Raman, Rema; Szabo, Paul; Gelmont, David M; Fritsch, Sandor; Aisen, Paul S
阿尔茨海默症
免疫/内分泌
发表日期：2017
文献求助 收藏

Response to the Letter to the Editor Regarding "Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials"

对编辑来信的回应，该信函主题为“临床试验中皮下注射免疫球蛋白（SCIG）局部不良反应的评估”。

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-017-0438-y
Suez, Daniel; Stein, Mark; Gupta, Sudhir; Hussain, Iftikhar; Melamed, Isaac; Paris, Kenneth; Darter, Amy; Bourgeois, Christelle; Fritsch, Sandor; Leibl, Heinz; McCoy, Barbara; Gelmont, David; Yel, Leman
免疫/内分泌
发表日期：2017
文献求助 收藏

Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies

一种新型人免疫球蛋白皮下注射剂（20%）的疗效、安全性、耐受性和药代动力学：一项在欧洲开展的针对原发性免疫缺陷患者的 2/3 期研究

期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1111/cei.12866
Borte, M; Kriván, G; Derfalvi, B; Maródi, L; Harrer, T; Jolles, S; Bourgeois, C; Engl, W; Leibl, H; McCoy, B; Gelmont, D; Yel, L
免疫/内分泌
发表日期：2017
文献求助 收藏

Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease

一项针对阿尔茨海默病老年患者的长期安慰剂对照研究证实了静脉注射免疫球蛋白的安全性

期刊:Alzheimer's and Dementia: Translational Research and Clinical Interventions
影响因子:6.8
doi:10.1016/j.trci.2016.06.003
Gelmont, David; Thomas, Ronald G; Britt, Jonathan; Dyck-Jones, Jacqueline A; Doralt, Jennifer; Fritsch, Sandor; Brewer, James B; Rissman, Robert A; Aisen, Paul
阿尔茨海默症
免疫/内分泌
发表日期：2016
文献求助 收藏

Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency

重组人透明质酸酶辅助皮下输注人免疫球蛋白治疗原发性免疫缺陷的长期耐受性、安全性和有效性

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-016-0298-x
Wasserman, Richard L; Melamed, Isaac; Stein, Mark R; Engl, Werner; Sharkhawy, Marlies; Leibl, Heinz; Puck, Jennifer; Rubinstein, Arye; Kobrynski, Lisa; Gupta, Sudhir; Grant, Andrew J; Ratnayake, Anoshie; Richmond, Wendell G; Church, Joseph; Yel, Leman; Gelmont, David
Human
免疫/内分泌
发表日期：2016
文献求助 收藏

Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America

北美地区20%新型人免疫球蛋白皮下注射剂治疗原发性免疫缺陷病患者的疗效、安全性和药代动力学研究

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-016-0327-9
Suez, Daniel; Stein, Mark; Gupta, Sudhir; Hussain, Iftikhar; Melamed, Isaac; Paris, Kenneth; Darter, Amy; Bourgeois, Christelle; Fritsch, Sandor; Leibl, Heinz; McCoy, Barbara; Gelmont, David; Yel, Leman
Human
免疫/内分泌
发表日期：2016
文献求助 收藏

THz-Spectroscopy of Biological Molecules

生物分子的太赫兹光谱

期刊:Journal of Biological Physics
影响因子:2.2
doi:10.1023/A:1024420104400
Globus, T R; Woolard, D L; Khromova, T; Crowe, T W; Bykhovskaia, M; Gelmont, B L; Hesler, J; Samuels, A C
发表日期：2003
文献求助 收藏